Weight loss stock wars: Key metrics to watch in Eli Lilly and Novo Nordisk results
Trending
- Why lower oil prices might not be enough to cool core inflation
- Weight loss stock wars: Key metrics to watch in Eli Lilly and Novo Nordisk results
- Canada’s monetary policy paused, inflation contained
- Recovery scenarios after SARB surprise – Commerzbank
- USD/JPY: The Yen Is No Longer a 1-Way Bet
- Scotiabank Sees More USD/CAD Pressure Ahead
- Australian Dollar remains stronger following China’s RatingDog Manufacturing PMI data
- U.S. stock futures rise as Trump touts Iran negotiations
Weight loss stock wars: Key metrics to watch in Eli Lilly and Novo Nordisk results
By Robert Jessi
